Provencio, M., Campos, B., Guirado, M., Vila, L., Campelo, R. G., Dorta, M., Estévez, S. V., Ferrández, A., Sala, M. Ã., Ortega, A. L., Blasco, A., Insa, A., Areses, M. C., Sullivan, I., Lopez, R., Calvo, V., Rodriguez-Abreu, D., Bosch-Barrera, J., López-Martín, A., Marsé, R., Torrado, L., Matskov, K., Giner, J., Bruno, M. F., Saugar, E. S., Martínez-Toledo, C., Mediavilla, P., Romero, A., Cruz-Bermúdez, A. (2025). Induction chemo-immunotherapy followed by chemo-radiotherapy and immunotherapy maintenance in stage III NSCLC (APOLO): a phase 2 trial. Nature Communications. https://doi.org/10.1038/s41467-025-66097-w